Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy
Targeting the inhibitory receptors (IRs) LAG-3, TIM-3 and TIGIT is a promising immune-oncology approach and the identification of biomarkers of response is crucial. Here, the authors apply automated single-cell count for these IRs in human renal cell carcinoma and investigate the immunogenomic lands...
Saved in:
Main Authors: | Kimiharu Takamatsu, Nobuyuki Tanaka, Kyohei Hakozaki, Ryohei Takahashi, Yu Teranishi, Tetsushi Murakami, Ryohei Kufukihara, Naoya Niwa, Shuji Mikami, Toshiaki Shinojima, Takashi Sasaki, Yusuke Sato, Haruki Kume, Seishi Ogawa, Kazuhiro Kakimi, Takashi Kamatani, Fuyuki Miya, Tatsuhiko Tsunoda, Eriko Aimono, Hiroshi Nishihara, Kazuaki Sawada, Takeshi Imamura, Ryuichi Mizuno, Mototsugu Oya |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f5c1a143c82843d6b1ca5c1840ac57f5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma
by: Qing Li, et al.
Published: (2021) -
Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma
by: Franziska Brauneck, et al.
Published: (2021) -
TIGIT limits immune pathology during viral infections
by: Michelle Schorer, et al.
Published: (2020) -
Implication of TIGIT+ human memory B cells in immune regulation
by: Md Mahmudul Hasan, et al.
Published: (2021) -
A novel scoring system for TIGIT expression in classic Hodgkin lymphoma
by: Ombretta Annibali, et al.
Published: (2021)